covid 19
-
COVID has taught us how to care for the sick and prepare for emergencies
If we can learn the lessons of the COVID pandemic to improve public health regarding respiratory diseases and become better prepared for the next pandemic, we will ensure that those whom COVID-19 has taken will not have died completely in…
-
Prescription Drug Q&A: The U.S. market and COVID vaccines
“The U.S. has a vibrant and thriving biopharma sector” – says American Enterprise Institute scholar and Milton Friedman chair James C. Capretta – “in large part because the payments system for these products is more favorable to the industry than…
-
Q&A: ‘Our blended program naturally allowed for ebb and flow of closures’
Because of the coronavirus pandemic, public charter schools like Canyon Grove Academy may soon become the norm for public schooling: creative and flexible, with individualized offerings that allow the creation of a school day as unique as the family and…
-
New healthcare study puts U.S. at No. 4 in world
The index offers clues into how countries, and by extension states in the U.S., can create market-driven systems that increase the value of healthcare; that is, produce higher quality results for less cost.
-
Transcript: Sutherland’s 2020 Congressional Series event with Rep. Ben McAdams
The following is an unedited transcription of remarks delivered by Rep. Ben McAdams (D-Utah) during Fiscal Responsibility, Transparency and Accountability During COVID-19.
-
Utah primed for COVID-19 recovery after new vote by pharmacy board
A unanimous vote in a public meeting of the Utah Board of Pharmacy this week moved to add “COVID-19 (SARS-CoV2)” to the list of vaccines approved for pharmacies to offer on the state’s Vaccine Administration Protocol.